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Klebsiella pneumoniae as a key trafficker of drug
resistance genes from environmental to clinically
important bacteria
Kelly L Wyres and Kathryn E Holt
Klebsiella pneumoniae is an opportunistic bacterial pathogen
known for its high frequency and diversity of antimicrobial
resistance (AMR) genes. In addition to being a significant
clinical problem in its own right, K. pneumoniae is the species
within which several new AMR genes were first discovered
before spreading to other pathogens (e.g. carbapenem-
resistance genes KPC, OXA-48 and NDM-1). Whilst K.
pneumoniae’s contribution to the overall AMR crisis is
impossible to quantify, current evidence suggests it has a
wider ecological distribution, significantly more varied DNA
composition, greater AMR gene diversity and a higher
plasmid burden than other Gram negative opportunists.
Hence we propose it plays a key role in disseminating AMR
genes from environmental microbes to clinically important
pathogens.
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Antimicrobial resistance in Gram negative
opportunistic pathogens
The antimicrobial resistance (AMR) crisis facing hospi-
tals globally is driven by the ESKAPE pathogens (Gram
positives Enterococcus faecium, Staphylococcus aureus; and
Gram negatives Klebsiella pneumoniae, Acinetobacter bau-
mannii, Pseudomonas aeruginosa, Enterobacter), which are
responsible for the majority of infections in hospital
patients that are difficult to manage with antimicrobial
therapy [1]. Notably the ESKAPE pathogens are envi-
ronmental or commensal bacteria that cause opportu-
nistic infections in hospitalised or immunocompromised
patients, but are generally not pathogenic otherwise.
Each of these species has intrinsic resistance to one or
more antibiotics, and individual strains have accumu-
lated resistance to many additional drugs [1]. The Gram
negative ESKAPE pathogens are considered the great-
est threat, due to the emergence of strains that are
resistant to all or most available antibiotics [2]. Accu-
mulation of AMR in these organisms is primarily due to
horizontal gene transfer (HGT) aided by plasmids and
mobile genetic elements [1]. The catalogue of known
mobile AMR genes subject to HGT amongst Gram
negative pathogens numbers in the hundreds [3]. The
origins of the AMR genes themselves are environmental
bacteria (particularly soil bacteria), assumed to be those
which have co-evolved with the relevant antimicrobial
producing organisms for millennia [4–6]; however there
is typically a lag of several years between the clinical use
of a drug and the arrival of relevant mobile AMR genes
in human pathogen populations [7]. Hundreds of mobile
AMR genes have been found in K. pneumoniae [8,9], the
species associated with the earliest reports of many
AMR genes before their dispersal amongst other clini-
cally relevant Gram negatives. Here we discuss this
phenomenon in detail, and then explore what is cur-
rently known about K. pneumoniae ecology and its
genome plasticity, arguing that these characteristics
position the species as a key amplifier and spreader of
AMR genes from environmental sources to human
pathogen populations.
The canary in the coalmine
K. pneumoniae are intrinsically resistant to ampicillin due
to the presence of the SHV-1 penicillinase in their
chromosome [8,10]. Resistance to additional drugs occa-
sionally arises through chromosomal mutations [11],
however most AMR in K. pneumoniae results from acqui-
sition of AMR genes via HGT, mainly via large conju-
gative plasmids [9,11,12]. The accumulation of resis-
tance determinants in a single strain can result in pan-
resistant strains that are untreatable with all available
antibiotics [2]. The earliest mobile ampicillin resis-
tance genes identified in Gram negative bacterial popu-
lations were TEM (present in the first described plas-
mids in the 1960s), and the K. pneumoniae chromosomal
SHV-1 gene which was first detected in mobile, plasmid-
borne form in other Enterobacteriaceae in 1973 [13,14]
(Figure 1). Following the introduction of third genera-
tion cephalosporins for clinical use in the early 1980s,
extended spectrum beta-lactamase (ESBL) genes con-
ferring resistance to these drugs began to be detected and
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characterised. The earliest forms include ESBL variants
of mobile SHV (SHV-2; 1985) [15], TEM (1984) and
CMY (1989) [16], which were first identified in K. pneu-
moniae (Figure 1) and are now widespread amongst
Enterobacteriaceae [17], and in some cases have also
spread to Acinetobacter [18] and Pseudomonas [19]. The
most widely dispersed ESBL gene is CTX-M, variants of
which were detected in Escherichia coli and K. pneumoniae
in the late 1980s and early 1990s, having been mobilised
out of environmental Enterobacteriaceae (Kluyvera)
[20,21]. CTX-M is now intimately associated with the
E. coli ST131 pandemic clone [22] and several K. pneu-
moniae clones [11], and is present in diverse plasmid
backgrounds, resulting in broad dissemination  amongst
hospital, human commensal, and animal associated
microbial populations [22,23].
The 1990s introduction of carbapenems and fluoroqui-
nolones were met by rapid appearance of associated
resistance genes, with K. pneumoniae often playing a
key role (Figure 1). Mobile quinolone resistance genes
qnrA and qnrB were first identified in K. pneumoniae
[24,25], following mobilisation from marine bacterium
Shewanella [26], and are now common amongst Entero-
bacteriaceae plasmids. The K. pneumoniae carbapenemase
(KPC) appeared in the mid-1990s in the USA and drove
the spread of pandemic hospital outbreak clone K. pneu-
moniae ST258, which is now globally disseminated [22].
The KPC gene has been transferred to many different
plasmids, is now widely dispersed amongst Enterobacter-
iaceae and has also found its way into Pseudomonas [27]
and Acinetobacter [28]. The OXA-48 carbapenemase ori-
ginates from Shewanella [29] and was first detected in K.
pneumoniae in Turkey in 2003 [30]. It was initially associ-
ated with hospital outbreaks across Europe and is now
reported worldwide [31], although not as widely dis-
persed as KPC. The NDM-1 metallo-beta-lactamase
was first detected in 2008 in K. pneumoniae from a patient
who had recently travelled to India [32]. The gene was
plasmid-borne and shortly thereafter was reported in
different K. pneumoniae strains isolated from patients with
and without recent travel [33]; by 2010 NDM-1 had
spread to numerous plasmids and Enterobacteriaceae
species, was detected within the chromosome of E. coli
and Providencia stuartii [34], and was spreading amongst
Acinetobacter and Pseudomonas [35,36]. The first mobile
colistin resistance gene MCR-1 was reported in China in
2015 in E. coli and K. pneumoniae [37]; by 2016 it had
been detected across five continents, among Enterobacter
and numerous other species, and in association with over
a dozen distinct plasmids [38].
It is impossible to accurately reconstruct the precise flow
of genes, plasmids and bacteria involved in the capture of
AMR genes from environmental microbes and their dis-
semination among human-associated bacterial pathogen
populations, although qnrA and OXA-48 provide compel-
ling examples of AMR gene mobilisation from marine
bacteria to K. pneumoniae, and onwards to other ESKAPE
pathogens. Regardless of precise HGT flow, the domi-
nance of K. pneumoniae amongst early clinical reports of
new AMR genes is notable, and indicates K. pneumoniae to
be a prime target for sentinel surveillance of new AMR
genes entering Gram negative pathogen populations.
Means and opportunity: genome plasticity,
plasmid diversity and ecology
Figure 2a shows the total number of distinct acquired
AMR genes and load per strain for all genome sequences
of K. pneumoniae and fellow Gram negative opportunists
(A. baumannii, P. aeruginosa, E. cloaceae and E. coli) cur-
rently in the NCBI Pathogen Genomes portal (>1400
genomes for each species). Over 400 acquired AMR genes
are present in the K. pneumoniae genomes, double the
number in E. coli and 50% more than that of the other
species (Figure 2a), suggesting that K. pneumoniae
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Figure 1
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Timeline of mobile AMR genes first detected in Klebsiella pneumoniae. Shading indicates the period since which isolates of K. pneumoniae
resistant to each drug class have been reported (regardless of mechanism). Selected mobile AMR genes that were first detected in K. pneumoniae
are labelled on the timeline, within the row corresponding to the relevant class; all have since been reported in clinically important
Enterobacteriaceae and other Gram negative bacteria. Note ampicillin resistance is intrinsic to K. pneumoniae due to the chromosomal beta-
lactamase gene SHV-1, and this gene was shown to be mobilised by plasmids in E. coli and K. pneumoniae in the 1970s. The other genes shown
did not originate in K. pneumoniae, but they were first detected in mobile form (i.e. within mobile genetic elements on plasmids) in K. pneumoniae
isolates, as detailed in the ‘The canary in the coalmine’ section.
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receives and/or amplifies a wider range of AMR genes
from their ultimate source in environmental microbes
[5,6]. Below we consider the genomic and ecological
characteristics of K. pneumoniae in comparison to the other
ESKAPE pathogens and E. coli, highlighting factors that
may enhance exposure to environmental AMR genes and
the ability to pass these genes on to other clinically
important pathogens.
Ecological range
Most HGT occurs between cells residing in the same
habitat [39], hence bacteria adapted to survive in envi-
ronmental and animal/human-associated microbial com-
munities can be predicted to contribute most to the
trafficking of AMR genes between these niches. Reports
in the 1970s–1980s highlighted the ubiquitous distribu-
tion of K. pneumoniae among diverse fresh and salt water
environments, plants, and soil [40]. K. pneumoniae causes
infections in cows, horses and other wild and domestic
animals [8,41,42,43,44–48]. However as an opportunistic
pathogen, it is likely that K. pneumoniae is more often a
component of the normal animal gut microbiota. In
humans the rate of intestinal K. pneumoniae colonisation
has been estimated at 6% [49,50], while in dairy cows
the rate may be much higher (44% among herds in New
York, USA, [51]). K. pneumoniae has also been cultured
from the faeces of other agricultural and domestic ani-
mals, from the cloacae of birds, and from fish, shellfish,
insects and earthworms [42,48,52–56]. It is a common
contaminant of animal and plant-based foods, which
likely plays a key role in introducing environmental
strains into the human gut [48].
Enterobacteriaceae are well known gut colonisers, and all
the ESKAPE pathogens can be isolated from environ-
mental sources [57], however systematic comparisons of
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Genome characteristics and burden of acquired AMR genes and plasmids in Gram negative ESKAPE pathogens and E. coli. (a) Acquired AMR
gene count per genome, extracted from the NCBI Pathogen Detection portal (>1400 genomes per species). The following intrinsic genes were
excluded: fosA, catB, aph(30)-IIb in P. aeruginosa; fosA, oqxA, oqxB in K. pneumoniae; fosA, catA, oqxB in E. cloacae; blaEC in E. coli. (b) and (c)
Number of plasmid replicons and protein-coding genes annotated in all complete genome sequences in NCBI GenBank (484 E. coli, 31 E.
cloaceae, 198 K. pneumoniae, 114 P. aeruginosa, 95 A. baumannii). (d) G + C content per gene annotated in the same set of complete genomes.
All data was downloaded from NCBI on March 19, 2018; code to generate plots is available in FigShare (https://doi.org/10.4225/49/
5ac3670f83717).
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isolation rates across environmental and animal sources
are lacking. We used the IMNGS website [58] to query
the growing body of publicly available 16S taxonomic
profiling data for the presence of Gram negative oppor-
tunists across a wide range of sample types
(Figure 3a). These data confirm the three Enterobacter-
iaceae species are frequent commensals of humans and
animals, with E. coli the most commonly detected; how-
ever K. pneumoniae and E. cloaceae showed equivalent or
even greater prevalence amongst plant and environmen-
tal samples (7–14%), whereas E. coli was significantly less
common in these niches (3–4%, p = 0.01). Notably these
data indicate that K. pneumoniae and E. cloaceae have
similarly broad ecological distributions, but K. pneumoniae
was more prevalent in human and other animal micro-
biomes (6.8% versus 3.6%), likely increasing its exposure
to antimicrobial use and its contact with other clinically
important pathogens, therefore enhancing amplification
and onward dissemination of acquired AMR genes.
It is difficult to directly assess movement of individual K.
pneumoniae strains between niches, however there is evi-
dence that isolates from human, animal and environmen-
tal sources do not represent distinct subpopulations
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Ecological distribution of species and sequence types based on public sequence data. (a) The IMNGS database (http://imngs.org, [58]) was
queried in March 2018 using one 16S rRNA sequence each from Klebsiella pneumoniae (NJST258_1), Acinetobacter baumannii (A1),
Pseudomonas aeruginosa (PA01), Enterobacter cloaceae (ATCC 13047) and E. coli (K-12), for hits with 99% identity and 200 bp. Bars indicate
mean frequency of detection (defined as relative abundance >0.1%) for each species in category descriptors containing 100 samples; error bars
indicate standard error of the mean. IMNGS output and code to generate plots is available in FigShare (https://doi.org/10.4225/49/
5ac3670f83717). (b) Top: globally distributed AMR STs reported from at least 2 non-human sources; CG258 = KPC-associated clonal group
258. Below: bar heights indicate number of isolates for which STs were reported in the literature (March 2018) and/or inferred from published
genome data. Data represent published STs from reports identified by PubMED search for ‘Klebsiella pneumoniae’ AND ‘ST*’ AND one of ‘cat’,
‘feline’, ‘dog’, ‘canine’, ‘cow’, ‘bovine’, ‘pig’, ‘porcine’, ‘water’, ‘aquatic’ (‘horse’ and ‘equine’ were also searched but yielded no reports of globally
distributed AMR STs); additional STs were compiled from two genomic studies which had each reported >10 isolates from non-human sources
[8,64].
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[8,42,48,59–61]. Clinically important K. pneumoniae
lineages have been isolated from specific non-human
sources (Figure 3b); for example, ESBL ST15 in cats
and dogs [59–61], and hypervirulent ST23 or ST25 in
horses, non-human primates and pigs [43,62,63]. Geno-
mic comparisons of K. pneumoniae from diverse sources are
rare but show little evidence of segregation between
niches: in a global diversity study, 59 bovine isolates were
distributed around the species phylogeny comprising
mostly human isolates [8]; and a comparison of ESBL
isolates from Thai hospitals and a local canal system
indicated phylogenetic intermingling [64]. These data
and others [48] confirm that at least some strains, includ-
ing those recognised as globally distributed hospital
pathogens [11], can move between and proliferate in
multiple niches, providing opportunity for genetic
exchange with a broad range of bacterial species
(Figure 3b).
Genome composition and HGT
K. pneumoniae genomes are highly diverse [8], comprising
hundreds of distinct phylogenetic lineages that differ
from each other by 0.5% nucleotide divergence. Indi-
vidual strains harbour 2000 ‘core’ (shared) genes, plus a
further 3500 accessory genes that differ between strains
and are drawn from a large pool of >30 000 [8]. The
2000 core genes likely facilitate K. pneumoniae’s broad
ecological range by providing metabolic and other capa-
bilities enabling survival in a wide range of niches. A
substantial proportion of the total pan-genome (core
+ accessory genes, [65]) is predicted to encode proteins
with metabolic functions; 19% associated with carbohy-
drate metabolism, 18% with other metabolic pathways
and 13% with membrane transport [8]. This extensive
diversity results in variable metabolic capacity [66],
potentially supplementing individual strains with addi-
tional ecological range and providing even more oppor-
tunities for genetic exchange. Direct comparison of pop-
ulation structures are difficult due to different sampling
and analysis strategies [65]; nonetheless it is clear that the
other Gram negative opportunists also have many deep
branching lineages and large pan-genomes [8,67–70].
Coding capacity and genome size are easy to compare
using public genome data (Figure 2c): K. pneumoniae has a
significantly larger genome than the other Enterobacter-
iaceae species considered here (mean 5.7 Mbp, 5455 pro-
tein coding genes, versus 5.1 Mbp/4915 genes in E. coli
and 5.0 Mbp/4680 genes in E. cloacae; p < 1  1015 using
two-sided t-test), which may help equip K. pneumoniae for
survival in a broader range of niches.
DNA base composition varies widely between taxa, and
can be used as a signature of bacterial species [71]. The
mean G + C content of K. pneumoniae core genes is 58%,
whereas that of accessory genes ranges from 20% to
>70%, suggesting they originate from a taxonomically
diverse array of donors [8]. Figure 2d shows that genes
annotated in complete genomes of K. pneumoniae display
significantly more variability in their G + C content than
those of the other species considered here, with 50%
greater variance in G + C content than E. coli and E.
cloaceae ( p < 1  1015 using F-test or the non-parametric
Fligner-Killeen test) and more than double the variance
of P. aeruginosa and A. baumannii. This suggests K. pneu-
moniae receives DNA from a wider diversity of HGT
partners; indeed lowest common ancestor analysis of K.
pneumoniae accessory genes has implicated >20 distinct
genera as DNA donors, including numerous other mem-
bers of the Enterobacteriaceae but also diverse groups
such as Acinetobacter, Burkholderia, Streptomyces, Vibrio,
Xanthomonas and Xyella [8]. More direct evidence for
K. pneumoniae engaging in inter-species HGT can be
found in recent genomic comparisons of carbapenem-
resistant Enterobacteriaceae in hospitals, which captured
identical or highly similar carbapenemase encoding plas-
mids and/or transposons from K. pneumoniae and other
species originating from the same ward and/or patient (E.
coli, E. cloacae, Enterobacter asburiae, Citrobacter freundii,
Klebsiella oxytoca, Raoultella ornothinolytica) [72,73,74].
Plasmid load
The vast majority of AMR genes in K. pneumoniae are
plasmid-borne [9,11], hence the ability to amplify and
spread AMR genes across ecological niches is likely
linked to plasmid-permissive traits. Highly diverse envi-
ronmental microbial communities, especially soils, are
considered hotspots for gene transfer [75], and Entero-
bacteriaceae have been identified as a component of the
‘super-permissive community’ that supports the spread of
plasmids across diverse soil communities [76]. The spe-
cific role of K. pneumoniae in such activities remains to be
explored, however the species has been associated with
hundreds of distinct plasmids spanning many plasmid
replicon types [8,9,12,77], which suggests it acts as a
recipient for plasmids originating from a wide array of
HGT donors. The median number of plasmids per com-
plete K. pneumoniae genome currently in NCBI GenBank
is three (interquartile range, 2–5; range 0–10), signifi-
cantly higher than that for the other species of interest
( p < 1  105, see Figure 2b). This is consistent with
numerous reports of K. pneumoniae strains carrying multi-
ple AMR plasmids; for example, the ST11 reference
genome, HS11286, harbours six plasmids (1.3–123 kbp
in size), three of which carry AMR genes [78]; and there
are many examples in other lineages [9,79,80].
Its elevated plasmid load (Figure 2b) suggests K. pneu-
moniae is particularly permissive for plasmids, meaning it
may be more likely to capture plasmid-borne material
from diverse donors in varied niches, and to hold on to this
material long enough to transmit it to new recipients in
human and animal-associated niches (Figure 4). This
enhanced permissiveness may reflect a comparatively
lower fitness burden of plasmid carriage in K. pneumoniae;
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a hypothesis supported by a small number of studies
showing lower fitness costs for specific AMR plasmids
in K. pneumoniae versus E. coli in vitro [81,82], and
reports of long-term plasmid maintenance in K. pneumo-
niae in vivo [63,72,82]. Plasmid–host interactions are
complex, and there are many reported examples of spe-
cific adaptations of hosts to plasmids (and vice versa)
[83,84]. It is has recently been shown that some chromo-
somal adaptations (such as helicase and RNA polymerase
mutations) can increase general plasmid permissiveness
of a host bacterium [84]. Intriguingly, it is clear that AMR
genes and plasmids are not randomly distributed amongst
K. pneumoniae lineages [8,9], suggesting that there may be
significant variation in plasmid permissiveness between
lineages. Related species and strains can vary substan-
tially in their ability to act as plasmid donors [76,85],
however variation in plasmid-donor potential between K.
pneumoniae and other bacteria, or between strains of K.
pneumoniae, remains to be investigated.
Conclusions
K. pneumoniae have the means and opportunity to capture
plasmids from environmental microbial populations; to
survive within and move between multiple environmen-
tal and animal-associated niches; to maintain AMR plas-
mids for prolonged periods; and to pass plasmids on to
other clinically important Gram negative bacteria (Fig-
ure 4). Whilst the contribution of K. pneumoniae to the
AMR crisis is impossible to quantify, the available
evidence suggests it is unique amongst the Gram negative
ESKAPE pathogens and E. coli in a few key respects
including its high diversity of acquired AMR genes, high
plasmid load, wide variability of G + C content reflecting
diverse HGT partners and broad ecological range —
whilst systematic studies of comparative ecology are
lacking, the available 16S data suggests K. pneumoniae
is equally likely to be found living in human, animal and
environmental niches. Combined these factors may posi-
tion K. pneumoniae as a key amplifier and spreader of
clinically important AMR genes. Better understanding
and monitoring of this highway of AMR gene transfer
could potentially help limit the spread of AMR and
prolong the life of new antibiotics.
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